Teil M - Search Results

1

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.

Teil M, Dovero S, Bourdenx M, Arotcarena ML, Darricau M, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Herrero MT, Vila M, Obeso JA, Bezard E, Dehay B. Teil M, et al. NPJ Parkinsons Dis. 2023 Sep 19;9(1):135. doi: 10.1038/s41531-023-00579-w. NPJ Parkinsons Dis. 2023. PMID: 37726343 Free PMC article.

2

Safety of medicines during breastfeeding - from case report to modeling: a contribution from the ConcePTION project.

Cardoso E, Guidi M, Nauwelaerts N, Nordeng H, Teil M, Allegaert K, Smits A, Gandia P, Edginton A, Ito S, Annaert P, Panchaud A. Cardoso E, et al. Among authors: teil m. Expert Opin Drug Metab Toxicol. 2023 Jan-Jun;19(5):269-283. doi: 10.1080/17425255.2023.2221847. Epub 2023 Jun 13. Expert Opin Drug Metab Toxicol. 2023. PMID: 37269321 Review.

3

The Zinc Ionophore Clioquinol Reduces Parkinson's Disease Patient-Derived Brain Extracts-Induced Neurodegeneration.

Teil M, Doudnikoff E, Thiolat ML, Bohic S, Bezard E, Dehay B. Teil M, et al. Mol Neurobiol. 2022 Oct;59(10):6245-6259. doi: 10.1007/s12035-022-02974-5. Epub 2022 Aug 2. Mol Neurobiol. 2022. PMID: 35915387

4

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.

Teil M, Dovero S, Bourdenx M, Arotcarena ML, Camus S, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Morari M, Meissner WG, Herrero MT, Vila M, Obeso JA, Bezard E, Dehay B. Teil M, et al. Brain. 2022 Apr 29;145(3):1001-1017. doi: 10.1093/brain/awab374. Brain. 2022. PMID: 35285474

5

Manufacturing of starch-based materials using ultrasonic compression moulding (UCM): toward a structural application.

Teil M, Regazzi A, Harthong B, Dumont PJJ, Imbault D, Putaux JL, Peyroux R. Teil M, et al. Heliyon. 2021 Mar 18;7(3):e06482. doi: 10.1016/j.heliyon.2021.e06482. eCollection 2021 Mar. Heliyon. 2021. PMID: 33817368 Free PMC article.

6

A New Rise of Non-Human Primate Models of Synucleinopathies.

Teil M, Arotcarena ML, Dehay B. Teil M, et al. Biomedicines. 2021 Mar 9;9(3):272. doi: 10.3390/biomedicines9030272. Biomedicines. 2021. PMID: 33803341 Free PMC article. Review.

7

L-DOPA regulates α-synuclein accumulation in experimental parkinsonism.

Deffains M, Canron MH, Teil M, Li Q, Dehay B, Bezard E, Fernagut PO. Deffains M, et al. Among authors: teil m. Neuropathol Appl Neurobiol. 2021 Jun;47(4):532-543. doi: 10.1111/nan.12678. Epub 2020 Dec 16. Neuropathol Appl Neurobiol. 2021. PMID: 33275784

8

Targeting α-synuclein for PD Therapeutics: A Pursuit on All Fronts.

Teil M, Arotcarena ML, Faggiani E, Laferriere F, Bezard E, Dehay B. Teil M, et al. Biomolecules. 2020 Mar 3;10(3):391. doi: 10.3390/biom10030391. Biomolecules. 2020. PMID: 32138193 Free PMC article. Review.

9

Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery.

Arotcarena ML, Teil M, Dehay B. Arotcarena ML, et al. Among authors: teil m. Cells. 2019 Jun 9;8(6):565. doi: 10.3390/cells8060565. Cells. 2019. PMID: 31181865 Free PMC article. Review.

10

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study.

Mariette X, Förger F, Abraham B, Flynn AD, Moltó A, Flipo RM, van Tubergen A, Shaughnessy L, Simpson J, Teil M, Helmer E, Wang M, Chakravarty EF. Mariette X, et al. Among authors: teil m. Ann Rheum Dis. 2018 Feb;77(2):228-233. doi: 10.1136/annrheumdis-2017-212196. Epub 2017 Oct 13. Ann Rheum Dis. 2018. PMID: 29030361 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page